The molecular understanding of super-enhancer dysregulation in cancer

Seiko Yoshino1, Hiroshi I Suzuki1,2

  • 1Division of Molecular Oncology, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Insights

Super-enhancers are key gene regulators involved in cell identity and disease. This review highlights their crucial roles in cancer, particularly in hematopoietic malignancies, and their potential as therapeutic targets.

Area of Science:

  • Genomics and Molecular Biology
  • Cancer Biology and Genetics

Background:

  • Gene expression regulation is critical for cellular function and implicated in disease.
  • Enhancers, particularly super-enhancers, are vital distal regulatory elements controlling cell-type-specific gene expression.
  • Super-enhancers are characterized by dense transcription factor binding, Mediator complex association, and active histone marks.

Purpose of the Study:

  • To review the multifaceted roles of super-enhancers in cancer biology.
  • To focus on the mechanisms of super-enhancer alterations in cancer, especially hematopoietic malignancies.
  • To explore the potential of super-enhancers as biomarkers and therapeutic targets in cancer.

Main Methods:

  • Literature review synthesizing current knowledge on super-enhancers in cancer.
  • Analysis of mechanisms involving transcription factor dysregulation and genomic abnormalities.
  • Focus on findings related to hematopoietic malignancies.

Main Results:

  • Super-enhancers play significant roles in cancer by activating oncogenes and shaping cancer cell gene expression.
  • Alterations in super-enhancer activity in cancer occur through various mechanisms, including transcription factor dysregulation.
  • Hematopoietic malignancies exhibit diverse reported mechanisms of super-enhancer alteration.

Conclusions:

  • Super-enhancers are critical regulators in cancer, influencing oncogene activation and cancer cell identity.
  • Understanding super-enhancer alterations offers opportunities for identifying cancer biomarkers.
  • Targeting super-enhancers presents a promising strategy for developing novel cancer therapeutics, particularly for transcriptional addiction.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K